One Wall Street Analyst Sees 50% Upside in SpaceX. Why I'm Still Not Buying the Stock.

Space Exploration Technologies is highlighted as highly valued at about $2 trillion market cap versus less than $19 billion in last year revenue, with bulls relying on aggressive 'what-if' assumptions around Starlink, a $1 trillion revenue target by 2030, Terafab, and Starship. Oppenheimer raised its price target from $190 to $250 and remains bullish, but the article argues the stock is overvalued and that key moonshot projects face major execution and technical risks. The piece is primarily analyst commentary and valuation debate, so near-term market impact is limited.

Analysis

The market is increasingly pricing SpaceX as if every adjacent ambition monetizes at near-best-case scale, which creates a fragile equity story: the valuation now depends less on current cash generation and more on sequential execution across multiple capital-intensive, regulatory-heavy businesses. That matters because the optionality is not independent; success in one layer (launch cadence, broadband densification, handset integration, orbital compute) is often a prerequisite for the next, so any delay compounds across the stack rather than remaining isolated.

The second-order winner from this debate is not necessarily the most obvious incumbent; it is the firms with scarce, already-deployed moats in adjacent infrastructure. TSMC benefits from the market re-learning how difficult leading-edge manufacturing actually is, while NVDA benefits if orbital compute or custom silicon remains aspirational rather than substitutable. Put differently, the more investors price in “SpaceX as a platform,” the more the public-market proxies for proven manufacturing, GPU acceleration, and advanced packaging deserve a scarcity premium.

The most underappreciated risk is time. Even if each moonshot is technically feasible, the capital intensity and regulatory drag mean the payback horizon is likely measured in years, while the stock is being marked on near-term narrative milestones. That creates a classic setup where any missed launch cadence, spectrum friction, handset adoption shortfall, or foundry delay can de-rate the whole complex quickly because the multiple has already capitalized the upside.

Consensus may be underestimating how little of the addressable market must actually be captured for the “story” to remain compelling, but also overestimating how much of it can be captured at attractive economics. The right framing is not “can SpaceX do this?” but “what margin structure survives if it does?” If the answer is subscale returns on huge incremental capital, the valuation can still compress even with continued operational wins.

Key Decisions for Investors

• Maintain/trim overweight TSM vs high-beta semiconductor exposures: prefer the proven manufacturing moat over speculative vertical integration bets; horizon 6-12 months, with asymmetric upside if market rotates toward execution quality.
• Add to NVDA on weakness as a proxy for real monetization of advanced compute demand; 3-9 month view, attractive if orbital/edge compute narratives remain optional rather than directly competitive.
• Avoid chasing private-market hype around SpaceX-linked adjacent themes until execution milestones are de-risked; the risk/reward is skewed negative after multiple expansion, especially over the next 1-2 quarters.
• Consider a pair: long TSM / short a basket of speculative aerospace-infrastructure names on any rally, targeting mean reversion if investors start distinguishing between capability and monetizable capability.
• For event risk, use call spreads rather than outright longs in NVDA around any catalyst tied to AI infrastructure demand; payoff is better if the market continues to reward real cash-flow conversion over far-future optionality.